ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1369

Sun Protection Use in Patients Followed in a Pediatric Rheumatology Clinic in an Urban Setting

Tom Elena Dubov1, Dawn Wahezi2, Evin Rothschild2, Tamar Rubinstein3 and Tamara Tanner4, 1NYCH+H/Jacobi, Bronx, NY, 2Children's Hospital at Montefiore, Bronx, NY, 3Albert Einstein College of Medicine, White Plains, NY, 4Montefiore Medical Center, Bronx, NY

Meeting: ACR Convergence 2022

Keywords: Pediatric rheumatology, practice guidelines, skin, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Pediatric Rheumatology – Clinical Poster II: Connective Tissue Disease

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Exposure to sunlight has been implicated as a major contributing factor in the pathogenesis of systemic lupus erythematosus (SLE) and juvenile dermatomyositis (JDM). Despite this evidence, assuring adequate sunscreen use in the pediatric rheumatology population remains a challenge and investigations into barriers to usage are inadequate. Similarly, the American Academy of Pediatrics recommends routine sun protective counseling, yet studies have shown suboptimal sunscreen use in the general pediatric population (13-34%). This study aims to investigate sun protection practices in patients of a pediatric rheumatology clinic.

Methods: We developed a survey that was offered to patients at routine visits in the pediatric rheumatology clinic at the Children’s Hospital at Montefiore, Bronx, NY. Patients surveyed had a variety of photosensitive and non-photosensitive conditions, including SLE, JDM, cutaneous lupus erythematosus (CLE), Juvenile Idiopathic Arthritis, and scleroderma. The survey was collected electronically via the Einstein-Montefiore REDCap (Research Electronic Data Capture), a secure web-based application for data collection.

To examine the association between disease activity of photosensitive skin conditions and adequate sun protection, we used validated disease activity tools, including SLE Disease Activity Index (SLEDAI) for SLE patients, defining active disease as SLEDAI >4 and Childhood Myositis Assessment Scale (CMAS) for JDM patients, defining active disease as CMAS< 45. Patient and physician global assessment (a 10cm VAS) were used as well, defining active disease >2 for each. Adequate sunscreen use was defined as reported sunscreen use daily or most days. Chi-square test was used to compare the different groups.

Results: We have enrolled 211 patients. Of these, 88 (42%) were diagnosed with a photosensitive skin condition including SLE, JDM or CLE. The median age was 15 years old (IQR 12, 18) with 75% female gender. Race and ethnicity were self-reported with 56% of patients identifying as Hispanic ethnicity; for race, 39% identified as Black, 18% white, 43% other. Most patients identified as having darker skin by the Fitzpatrick scale. While 62% of patients agreed that sun protection is important, only 36% overall reported appropriate sunscreen use. Factors associated with adequate sunscreen use were having a photosensitive skin condition (P< 0.0001) and recall of counseling on sunscreen use at initial diagnosis (P< 0.0001) (Table 1). When examining the association between disease activity and adequate sunscreen use, no statistically significant association was found. Seasonal variation of adequate sun protection was observed in patients with photosensitive conditions (figure 1). Less than 50% reported adequate sunscreen use in the winter as opposed to other seasons.

Conclusion: This study identifies gaps in sun protection use in a large proportion of pediatric patients with rheumatologic diseases, including those with photosensitive skin diseases. Patient counseling and education may be a key factor for adequate sun protection, especially early on during the initial diagnosis.

Supporting image 1

Table 1: Patients characteristics by adequate vs inadequate sun protection groups

Supporting image 2

Figure 1: Seasonal variation in adequate sun protection in patients with photosensitive condition


Disclosures: T. Dubov, None; D. Wahezi, None; E. Rothschild, None; T. Rubinstein, None; T. Tanner, None.

To cite this abstract in AMA style:

Dubov T, Wahezi D, Rothschild E, Rubinstein T, Tanner T. Sun Protection Use in Patients Followed in a Pediatric Rheumatology Clinic in an Urban Setting [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/sun-protection-use-in-patients-followed-in-a-pediatric-rheumatology-clinic-in-an-urban-setting-2/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sun-protection-use-in-patients-followed-in-a-pediatric-rheumatology-clinic-in-an-urban-setting-2/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology